430 related articles for article (PubMed ID: 28232487)
1. Fatty acid synthase inhibits the
Groves JA; Maduka AO; O'Meally RN; Cole RN; Zachara NE
J Biol Chem; 2017 Apr; 292(16):6493-6511. PubMed ID: 28232487
[TBL] [Abstract][Full Text] [Related]
2. The Nutrient-Dependent O-GlcNAc Modification Controls the Expression of Liver Fatty Acid Synthase.
Baldini SF; Wavelet C; Hainault I; Guinez C; Lefebvre T
J Mol Biol; 2016 Aug; 428(16):3295-3304. PubMed ID: 27185461
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe.
Kositzke A; Fan D; Wang A; Li H; Worth M; Jiang J
Int J Biol Macromol; 2021 Feb; 169():51-59. PubMed ID: 33333092
[TBL] [Abstract][Full Text] [Related]
4. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation increases ChREBP protein content and transcriptional activity in the liver.
Guinez C; Filhoulaud G; Rayah-Benhamed F; Marmier S; Dubuquoy C; Dentin R; Moldes M; Burnol AF; Yang X; Lefebvre T; Girard J; Postic C
Diabetes; 2011 May; 60(5):1399-413. PubMed ID: 21471514
[TBL] [Abstract][Full Text] [Related]
7. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain.
Liu Y; Li X; Yu Y; Shi J; Liang Z; Run X; Li Y; Dai CL; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX
PLoS One; 2012; 7(8):e43724. PubMed ID: 22928023
[TBL] [Abstract][Full Text] [Related]
8. Excessive
Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
[TBL] [Abstract][Full Text] [Related]
9. E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression.
Muthusamy S; Hong KU; Dassanayaka S; Hamid T; Jones SP
J Biol Chem; 2015 Dec; 290(52):31013-24. PubMed ID: 26527687
[TBL] [Abstract][Full Text] [Related]
10. Yeast cells as an assay system for in vivo O-GlcNAc modification.
Nakanishi H; Li F; Han B; Arai S; Gao XD
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
[TBL] [Abstract][Full Text] [Related]
11. Cryo-EM structure of human O-GlcNAcylation enzyme pair OGT-OGA complex.
Lu P; Liu Y; He M; Cao T; Yang M; Qi S; Yu H; Gao H
Nat Commun; 2023 Oct; 14(1):6952. PubMed ID: 37907462
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcase Expression is Sensitive to Changes in O-GlcNAc Homeostasis.
Zhang Z; Tan EP; VandenHull NJ; Peterson KR; Slawson C
Front Endocrinol (Lausanne); 2014; 5():206. PubMed ID: 25520704
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity.
Narayanan B; Sinha P; Henry R; Reeves RA; Paolocci N; Kohr MJ; Zachara NE
J Biol Chem; 2023 Dec; 299(12):105447. PubMed ID: 37949223
[TBL] [Abstract][Full Text] [Related]
14. O-Linked N-Acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Interact with Mi2β Protein at the Aγ-Globin Promoter.
Zhang Z; Costa FC; Tan EP; Bushue N; DiTacchio L; Costello CE; McComb ME; Whelan SA; Peterson KR; Slawson C
J Biol Chem; 2016 Jul; 291(30):15628-40. PubMed ID: 27231347
[TBL] [Abstract][Full Text] [Related]
15. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity.
Nagel AK; Ball LE
Amino Acids; 2014 Oct; 46(10):2305-16. PubMed ID: 25173736
[TBL] [Abstract][Full Text] [Related]
17. Nucleocytoplasmic human O-GlcNAc transferase is sufficient for O-GlcNAcylation of mitochondrial proteins.
Trapannone R; Mariappa D; Ferenbach AT; van Aalten DM
Biochem J; 2016 Jun; 473(12):1693-702. PubMed ID: 27048592
[TBL] [Abstract][Full Text] [Related]
18. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
[TBL] [Abstract][Full Text] [Related]
19. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
[TBL] [Abstract][Full Text] [Related]
20. Characterization of O-GlcNAc cycling and proteomic identification of differentially O-GlcNAcylated proteins during G1/S transition.
Drougat L; Olivier-Van Stichelen S; Mortuaire M; Foulquier F; Lacoste AS; Michalski JC; Lefebvre T; Vercoutter-Edouart AS
Biochim Biophys Acta; 2012 Dec; 1820(12):1839-48. PubMed ID: 22967762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
